<?xml version="1.0" encoding="UTF-8"?>
<urlset
  xmlns="http://www.sitemaps.org/schemas/sitemap/0.9"
  xmlns:news="http://www.google.com/schemas/sitemap-news/0.9">
  <url>
    <loc>https://www.weightlossrankings.org/research/retatrutide-approval-access-timeline-2026-2027</loc>
    <news:news>
      <news:publication>
        <news:name>Weight Loss Rankings</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-05-09T00:00:00.000Z</news:publication_date>
      <news:title>Retatrutide Approval &amp; Access Timeline 2026-27: TRIUMPH Readouts, NDA Path, and Why You Cannot Legally Compound It</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://www.weightlossrankings.org/research/glp1-pcos-polycystic-ovary-syndrome-evidence</loc>
    <news:news>
      <news:publication>
        <news:name>Weight Loss Rankings</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-05-09T00:00:00.000Z</news:publication_date>
      <news:title>GLP-1s for PCOS (Polycystic Ovary Syndrome) Evidence &amp; Insurance Coverage 2026: Off-Label Use, Trial Data &amp; How to Get Approved</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://www.weightlossrankings.org/research/foundayo-orforglipron-week-by-week-titration-guide</loc>
    <news:news>
      <news:publication>
        <news:name>Weight Loss Rankings</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-05-09T00:00:00.000Z</news:publication_date>
      <news:title>Foundayo (Orforglipron) Week-by-Week (2026): Days 1-90 Titration Schedule, What to Expect &amp; Common Questions</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://www.weightlossrankings.org/research/glp1-body-dysmorphia-disclosure-post-loss-grief-guide</loc>
    <news:news>
      <news:publication>
        <news:name>Weight Loss Rankings</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-05-09T00:00:00.000Z</news:publication_date>
      <news:title>Body Dysmorphia, Disclosure &amp; Post-Loss Grief on GLP-1 (2026): The Psychosocial Side of Rapid Weight Loss</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://www.weightlossrankings.org/research/glp1-mental-health-anhedonia-emotional-blunting-evidence</loc>
    <news:news>
      <news:publication>
        <news:name>Weight Loss Rankings</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-05-09T00:00:00.000Z</news:publication_date>
      <news:title>GLP-1s &amp; Mental Health (2026): What the FDA&apos;s January 2026 Suicidality Warning Removal Means for Mood, Anhedonia &amp; Depression</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://www.weightlossrankings.org/research/zepbound-vs-wegovy-cost-comparison</loc>
    <news:news>
      <news:publication>
        <news:name>Weight Loss Rankings</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-05-09T00:00:00.000Z</news:publication_date>
      <news:title>Zepbound vs Wegovy Cost (2026): Self-Pay, Insurance Copay, Caremark Formulary &amp; Total-Cost Comparison</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://www.weightlossrankings.org/research/life-after-glp1-maintenance-decision-hub</loc>
    <news:news>
      <news:publication>
        <news:name>Weight Loss Rankings</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-05-09T00:00:00.000Z</news:publication_date>
      <news:title>Life After GLP-1: Maintenance Dosing, Microdosing, Tapering &amp; What Happens When You Stop (2026 Decision Hub)</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://www.weightlossrankings.org/research/glp1-insurance-dropped-coverage-appeal-playbook</loc>
    <news:news>
      <news:publication>
        <news:name>Weight Loss Rankings</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-05-09T00:00:00.000Z</news:publication_date>
      <news:title>Insurance Dropped Your GLP-1? The Complete Appeal Playbook for CVS Caremark, Cigna, Aetna, UHC (2026)</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://www.weightlossrankings.org/research/qsymia-phentermine-topiramate-weight-loss-evidence</loc>
    <news:news>
      <news:publication>
        <news:name>Weight Loss Rankings</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-05-09T00:00:00.000Z</news:publication_date>
      <news:title>Qsymia (Phentermine + Topiramate ER) for Weight Loss: FDA Label, CONQUER Evidence &amp; How It Compares to GLP-1s (2026)</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://www.weightlossrankings.org/research/best-appetite-suppressant-fda-approved-2026</loc>
    <news:news>
      <news:publication>
        <news:name>Weight Loss Rankings</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-05-09T00:00:00.000Z</news:publication_date>
      <news:title>Best Appetite Suppressant 2026: FDA-Approved Pills, Injections &amp; Drugs Compared</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://www.weightlossrankings.org/research/ozempic-alternatives-complete-guide-2026</loc>
    <news:news>
      <news:publication>
        <news:name>Weight Loss Rankings</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-05-09T00:00:00.000Z</news:publication_date>
      <news:title>Ozempic Alternatives (2026): FDA-Approved GLP-1s, Cheaper Semaglutide &amp; Non-GLP-1 Options</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://www.weightlossrankings.org/research/zepbound-generic-tirzepatide-biosimilar-timeline</loc>
    <news:news>
      <news:publication>
        <news:name>Weight Loss Rankings</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-05-09T00:00:00.000Z</news:publication_date>
      <news:title>Zepbound Generic / Tirzepatide Biosimilar: When Will It Be Available? (2026 Status)</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://www.weightlossrankings.org/research/zepbound-vs-wegovy-side-effects-comparison</loc>
    <news:news>
      <news:publication>
        <news:name>Weight Loss Rankings</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-05-09T00:00:00.000Z</news:publication_date>
      <news:title>Zepbound vs Wegovy Side Effects: Head-to-Head Comparison from the FDA Labels (2026)</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://www.weightlossrankings.org/research/diabetes-vs-weight-loss-glp1-medication-disambiguation</loc>
    <news:news>
      <news:publication>
        <news:name>Weight Loss Rankings</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-05-09T00:00:00.000Z</news:publication_date>
      <news:title>Diabetes Weight Loss Drug — Which Is Which? Untangling Ozempic, Mounjaro, Wegovy, Zepbound, Foundayo (2026)</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://www.weightlossrankings.org/research/wegovy-vs-mounjaro-different-molecules-decision-guide</loc>
    <news:news>
      <news:publication>
        <news:name>Weight Loss Rankings</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-05-09T00:00:00.000Z</news:publication_date>
      <news:title>Wegovy vs Mounjaro: Different Molecules, Different Indications — How to Choose (2026)</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://www.weightlossrankings.org/research/wegovy-goodrx-glp1-cash-pay-coupon-channel-guide</loc>
    <news:news>
      <news:publication>
        <news:name>Weight Loss Rankings</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-05-09T00:00:00.000Z</news:publication_date>
      <news:title>Wegovy GoodRx, NovoCare $299, Costco $349, Sam&apos;s Club: Every GLP-1 Cash-Pay Coupon &amp; Channel (2026)</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://www.weightlossrankings.org/research/mounjaro-vs-zepbound-complete-comparison</loc>
    <news:news>
      <news:publication>
        <news:name>Weight Loss Rankings</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-05-09T00:00:00.000Z</news:publication_date>
      <news:title>Mounjaro vs Zepbound: Same Drug, Different Brand Names — Complete Side-by-Side Comparison (2026)</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://www.weightlossrankings.org/research/bariatric-surgery-vs-glp1-decision-guide</loc>
    <news:news>
      <news:publication>
        <news:name>Weight Loss Rankings</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-05-09T00:00:00.000Z</news:publication_date>
      <news:title>Bariatric Surgery vs GLP-1 vs Combination: A Decision Guide With 13 Verified Trials</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://www.weightlossrankings.org/research/aetna-glp1-prior-authorization-guide</loc>
    <news:news>
      <news:publication>
        <news:name>Weight Loss Rankings</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-05-09T00:00:00.000Z</news:publication_date>
      <news:title>Aetna GLP-1 Prior Authorization Guide: Verbatim PA Criteria for Wegovy, Zepbound, Saxenda, Ozempic, and Mounjaro (2026)</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://www.weightlossrankings.org/research/cigna-glp1-prior-authorization-guide</loc>
    <news:news>
      <news:publication>
        <news:name>Weight Loss Rankings</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-05-09T00:00:00.000Z</news:publication_date>
      <news:title>Cigna GLP-1 Prior Authorization Guide: Verbatim PA Criteria for Wegovy, Zepbound, Foundayo, Ozempic, and Mounjaro (2026)</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://www.weightlossrankings.org/research/aetna-glp1-autorizacion-previa-guia</loc>
    <news:news>
      <news:publication>
        <news:name>Weight Loss Rankings</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-05-09T00:00:00.000Z</news:publication_date>
      <news:title>Guía de autorización previa de Aetna para GLP-1: criterios textuales para Wegovy, Zepbound, Saxenda, Ozempic y Mounjaro (2026)</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://www.weightlossrankings.org/research/cigna-glp1-autorizacion-previa-guia</loc>
    <news:news>
      <news:publication>
        <news:name>Weight Loss Rankings</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-05-09T00:00:00.000Z</news:publication_date>
      <news:title>Guía de autorización previa de Cigna para GLP-1: criterios textuales para Wegovy, Zepbound, Foundayo, Ozempic y Mounjaro (2026)</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://www.weightlossrankings.org/research/cirugia-bariatrica-vs-glp1-guia-decision</loc>
    <news:news>
      <news:publication>
        <news:name>Weight Loss Rankings</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-05-09T00:00:00.000Z</news:publication_date>
      <news:title>Cirugía bariátrica vs GLP-1 vs combinación: guía de decisión con 13 ensayos verificados</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://www.weightlossrankings.org/research/mounjaro-zepbound-fda-prescribing-information-explained</loc>
    <news:news>
      <news:publication>
        <news:name>Weight Loss Rankings</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-05-09T00:00:00.000Z</news:publication_date>
      <news:title>Mounjaro vs Zepbound: FDA Prescribing Information Explained Side-by-Side</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://www.weightlossrankings.org/research/mounjaro-zepbound-informacion-prescripcion-fda</loc>
    <news:news>
      <news:publication>
        <news:name>Weight Loss Rankings</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-05-09T00:00:00.000Z</news:publication_date>
      <news:title>Mounjaro vs Zepbound: La información de prescripción de la FDA explicada lado a lado</news:title>
    </news:news>
  </url>
</urlset>